Gilead Sciences (GILD) Change in Inventory (2009 - 2026)

Gilead Sciences (GILD) has reported Change in Inventory for 18 consecutive years, with $145.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Change in Inventory fell 17.14% year-over-year to $145.0 million; the trailing twelve-month figure through Jun 2026 stood at $835.0 million (up 17.77% YoY), and the FY2025 full-year result was $1.0 billion, up 143.19% from the prior year.
• Change in Inventory grew to $145.0 million in Q2 2026 per GILD's latest filing, from $52.0 million in the prior quarter.
• Across five years, Change in Inventory topped out at $515.0 million in Q3 2025 and bottomed at -$53.0 million in Q1 2022.
• Historically, Change in Inventory has averaged $156.2 million across 5 years, with a median of $134.0 million in 2025.
• The sharpest annual moves came in 2022 and 2023: Change in Inventory slumped 176.81% in 2022, then jumped 2925.0% in 2023.
• Over 5 years, Change in Inventory stood at $276.0 million in 2022, then advanced by 11.23% to $307.0 million in 2023, then fell by 26.38% to $226.0 million in 2024, then tumbled by 45.58% to $123.0 million in 2025, then climbed by 17.89% to $145.0 million in 2026.
• According to Business Quant data, Change in Inventory over the past three periods registered $145.0 million, $52.0 million, and $123.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.